Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Assessing early market opportunity

To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

- PMLiVE

Type 2 diabetes can be reversed in just four months, say researchers

A controlled diet and a strict exercise regime could help cure type 2 diabetes

- PMLiVE

The potential of programmatic

Consumers desire messages which are personalised and relevant to their needs

National Institute for Health and Care Excellence NICE logo

NICE agrees £20m cost ceiling for new drugs

New budget test set to begin from April and could delay uptake of new medicines

- PMLiVE

La La Land? The myth of multichannel excellence

Pharma is still experiencing growing pains in multichannel marketing

- PMLiVE

Caring for prostate cancer patients

Although not without its challenges, the appropriate care and support available to patients with prostate cancer is gradually evolving. It’s important not to overlook the all too often ‘unsung heroes’...

Blue Latitude Health

- PMLiVE

AXON announces new roles for senior team members

Emma Kenny, Andy Grigg and Emma Lemon take on new responsibilities

- PMLiVE

Pfizer launches new antibiotic Zavicefta in UK and Germany

Biopharmaceutical company Pfizer releases MDR antibiotic

- PMLiVE

Keytruda claims first blood cancer OK from FDA

Merck & Co wins US approval for its haematological cancer treatment

- PMLiVE

Cello Health Consulting expands its UK team

Appoints John Tarplee, Eric de Regnaucourt, Jakub Kaczor and Namhee Lim

- PMLiVE

Mylan deal with Roche clears path to biosimilar Herceptin launch

Covers global markets with the exception of Japan, Brazil and Mexico

Dr Gopalan Narayanan joins VCLS

He takes up a 'disruptive biologics' role at the product development consultancy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links